This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Molina Healthcare (MOH) Tops Q2 Earnings, Updates '18 View
by Zacks Equity Research
Molina Healthcare's (MOH) Q2 gains from a decline in expense. The company also revises its full-year guidance.
WellCare Health (WCG) Beats on Q2 Earnings, Updates Guidance
by Zacks Equity Research
WellCare Health's (WCG) second-quarter 2018 rides high on solid segmental performances.
Top Ranked Growth Stocks to Buy for August 1st
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, August 1st:
Community Health (CYH) Incurs Lower Loss Than Expected in Q2
by Zacks Equity Research
Community Health's (CYH) Q2 results suffer loss from decline in admissions.
Universal Health (UHS) Q2 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
Universal Health's (UHS) second-quarter earnings benefit from solid performances by the Acute Care and Behavioral Hospitals.
HCA Healthcare (HCA) Beats on Q2 Earnings, Revises Guidance
by Zacks Equity Research
HCA Healthcare's (HCA) second-quarter earnings grow on the back of solid revenues and increased admissions.
Anthem (ANTM) Q2 Earnings Beat, Membership Declines, View Up
by Zacks Equity Research
Anthem (ANTM) Q2 earnings gain on medical cost improvement, partly offset by membership declines.
Centene (CNC) Beats Q2 Earnings Estimates, Revises Guidance
by Zacks Equity Research
Centene's (CNC) second-quarter earnings beat on revenue and membership growth. The top line improves owing to Health Insurance Marketplace business, acquisitions and expansions.
Dow 30 Stock Roundup: Goldman Sachs, IBM, J&J, Microsoft Earnings Impress
by Swarup Gupta
The index posted impressive gains this week, boosted by a strong economy and expectations of robust earnings.
4 Big-Name Stocks to Buy on Blockbuster Q2 Earnings
by Tirthankar Chakraborty
We select four big names that have reported remarkable second-quarter results and are poised to scale north on solid fundamentals.
Dow Posts Longest Winning Run in Two Months: 4 Top Picks
by Nalak Das
A strong bunch of 15 stocks out of the portfolio of 30 in the Dow has provided positive returns year to date.
Healthcare ETFs to Ride on UnitedHealth's Solid Q2 & Outlook
by Sweta Killa
Investors should tap the opportunity with ETFs having the largest allocation to UnitedHealth.
Company News For Jul 18, 2018
by Zacks Equity Research
Companies in the news are: UNH, CMA, WMT, MSFT, GS
Why Dip in UnitedHealth Stock Post Q2 is a Good Entry Point
by Zacks Equity Research
Despite concerns over some parts of UnitedHealth's (UNH) Q2 earnings, its long-term growth prospects are bright.
Watch Out For Goldman
by Zacks Equity Research
Watch Out For Goldman
Goldman Beats in Blankfein's Final Quarter
by Mark Vickery
Goldman Sachs (GS) CEO and Chairman Lloyd Blankfein announced his replacement this morning as the company he's run for the past 12 years easily beat earnings and revenue projections in its Q2 report.
UnitedHealth's (UNH) Q2 Earnings Beat, 2018 Guidance Up
by Zacks Equity Research
UnitedHealth (UNH) Q2 earnings beat on membership growth, 2018 guidance pulled up.
UnitedHealth (UNH) Q2 Earnings Beat on Revenue Growth
by Zacks Equity Research
UnitedHealth's (UNH) Q2 earnings gained on revenue and membership growth.
UnitedHealth (UNH) Loses 0.7% Ahead of Earnings: What To Watch
by Ryan McQueeney
Shares of UnitedHealth (UNH) lost about 0.7% during regular hours Monday, the last day of trading before it releases its latest quarterly earnings report. Here's what to expect on Tuesday morning.
The 5 Most Spectacular Earnings Charts This Week
by Tracey Ryniec
These stocks are among the hottest on the Street. Can they keep their upward momentum?
How Will Membership Affect UnitedHealth's (UNH) Q2 Earnings?
by Zacks Equity Research
UnitedHealth (UNH) should see an increase in Public Group and International business, partially offset by lower commercial membership.
Will Higher Revenues Aid UnitedHealth's (UNH) Q2 Earnings?
by Zacks Equity Research
Continued strong performance across the company to aid UnitedHealth's (UNH) results.
JNJ vs. NVS: Which Stock is Better Pre Q1 Earnings?
by Zacks Equity Research
With Johnson & Johnson (JNJ) and Novartis AG (NVS) scheduled to report on Jul 17 and Jul 18, respectively, this may be a good time to figure out which of these is a better stock.
Trade Wars and Recessions: What Should Investors Do?
by Tracey Ryniec
The best thing investors can do is have a plan. Find out where you should be investing in this uncertain market.
Top Stock Picks for the Week of July 9th
by Panel Of Zacks Experts
Two Outperforming Companies in the Healthcare arena.